Navigation Links
Idenix Pharmaceuticals Reports First Quarter Financial Results
Date:4/30/2009

4 894 Other current assets 4,859 6,214 ----- ----- Total current assets 68,240 50,041 Intangible asset, net 12,097 12,387 Property and equipment, net 12,157 13,238 Marketable securities, non-current 1,900 3,145 Other assets 2,084 969 ----- --- Total assets $96,478 $79,780 ======= ======= LIABILITIES AND STOCKHOLDERS' EQUITY Accounts payable and accrued expenses $10,051 $13,136 Deferred revenue, related party 6,130 5,965 Other current liabilities 1,560 475 ----- --- Total current liabilities 17,741 19,576 Long-term obligations 33,845 17,061 Deferred revenue, related party, net of current portion 35,246 35,790 ------ ------ Total liabilities 86,832 72,427 Stockholders' equity 9,646 7,353 ----- ----- Total liabilities and stockholders' equity $96,478 $79,780 ======= =======


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
9. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15 septembre 2014 La deuxième édition ... (semaine internationale sur la sensibilisation au plasma) ... conjointe de la Plasma Protein Therapeutics Association ... , l,IPAW vise à : , ... la collecte du plasma-aphérèse , Reconnaître la ...
(Date:9/14/2014)... Cells regulate protein functions in a wide variety of ... instant, a protein can take on another form and ... proteins that fold wrongly can cause serious diseases such ... proteins also have a tendency to "infect" other molecules ... amyloid fibrils or plaques. These amyloids can damage cells ...
(Date:9/12/2014)... Advancing the front lines of research ... biological threats is the mission of an international ... and the Georgian National Academy of Sciences, and ... Security Programme of the North Atlantic Treaty Organization ... series, the event is titled “Nanotechnology to Aid ...
(Date:9/11/2014)... 2014 RURO, Inc., a leading ... solutions and sample management solutions provider, announces the ... work on the most recent version of its ... already seen mass adoption, especially from multi-license environment ... 5.0 brought an entirely new User Interface and ...
Breaking Biology Technology:L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Measuring modified protein structures 2Measuring modified protein structures 3Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Limfinity® Version 5.1 Available 2
... Oct. 27 /Xinhua-PRNewswire/ -- Recently, China Green,Material ... Intellectual,Property Office for two patents for Industrialized ... and Industrialized Production,Method of Fully Biodegradable Edible ... applications have both obtained acceptance numbers,200810064592 and ...
... Ceftaroline, a Novel, Broad-Spectrum Cephalosporin in,Development for Complicated ... Pneumonia (CAP), WASHINGTON, Oct. 27, 2008 ... detailed analysis of CANVAS I, a,globally conducted, multi-center, ... Conference on Antimicrobial Agents and Chemotherapy /,Infectious Diseases ...
... November 2, 2008 at this year,s liver ... - November 4, SAN FRANCISCO, Oct. 27 ... is no approved,medical therapy for this chronic progressive liver ... state-of-the-art lifestyle,intervention program. To do so, 31 overweight or ...
Cached Biology Technology:Patent Technologies Keep CGMT in a Leading Position in the Industry 2Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 2Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 3Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 4Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 5Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 6Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 7Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA 8Intensive Lifestyle Intervention Program for Overweight or Obese Patients with Nonalcoholic Steatohepatitis Reduces Weight and Improves Overall Liver Health 2
(Date:9/15/2014)... lifeplants and animalsto thrive in the oceans, there ... In certain coastal areas, extreme oxygen-starvation produces "dead ... web structure. As dissolved oxygen levels decline, energy ... microbial community metabolism resulting in impacts on the ... the past 50 years, oxygen minimum zones (OMZs) ...
(Date:9/15/2014)... that affect hearing and cognitive function may play roles ... and perceive rhythm, pitch, timbre, tone durations, and formal ... BioEssays article explain that extremes in musical aptitude ... the majority of individuals having moderate aptitude. , "This ... to several underlying genes, and it is influenced to ...
(Date:9/15/2014)... hippopotamuses are demonstrably shown swimming or floating at the ... can,t swim, how did they reach and colonize islands? ... methods, patterns, and timing of the colonization and dispersal ... need to be reconsidered. , "Although land bridge connections ... currently supported by positive geological evidence, neither is ...
Breaking Biology News(10 mins):Decoding virus-host interactions in the oxygen-starved ocean 2Decoding virus-host interactions in the oxygen-starved ocean 3Decoding virus-host interactions in the oxygen-starved ocean 4Decoding virus-host interactions in the oxygen-starved ocean 5
... The octopus arm is extremely flexible. Thanks to ... virtually infinite number of "degrees of freedom"--the octopus ... movements that is unmatched by the human arm. ... differences between the octopus and vertebrates, the octopus ...
... Environmental and genetic factors lead to neural tube defects in 1 ... spontaneous abortion. One cause of these defects is the failure of ... the developing neural tube. , A study in ... the molecular mechanism that directs cells to migrate to the correct ...
... in food-producing animals may be linked with lower levels ... an article in the May 15 issue of Clinical ... is a leading bacterial cause of foodborne illness in ... for physicians to treat, and can result in longer ...
Cached Biology News:How the octopus forms an elbow 2Less antibiotic use in food animals leads to less drug resistance in people, study shows 2
Antibeta-lactoglobulin monoclonal antibody(CD-2)...
MAb to Vasopressin Preservative: NaN3...
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
Biology Products: